retatrutide triple agonist gip glp-1 glucagon phase 3 2025 Today, we shared new data from two trials of retatrutide, our investigational agonist. Learn more at our link in bio Retatrutide for Weight Loss: What

Qiang, J

Rather than simply suppressing symptoms, we can now target the underlying inflammatory pathways while simultaneously promoting repair and regeneration

This includes gastroparesis (a condition that happens when the stomach empties its contents more slowly than usual)

The TGA said it has been alerted to severe allergic reactions that have led to hospitalisation, severe inflammation, full-body intense itching, palpitations, pain, insomnia, blurred vision and musculoskeletal injuries as a result of using retatrutide

How Injectable Semaglutide Works Using a pre-filled pen or vial, you inject the semaglutide into fatty tissue